PharmaRoth Labs, Inc. (ROTH)

[old biohf guy]

Yes, I mean that study. It was started in June and ran for 12 weeks ending in September 2016.

The fact is the study is very real. The results were analyzed and scrutinized extensively for several reasons, both planned and unplanned, but all hurdles have been overcome. Published results are due very soon.

This is a very important major study comparing Sucanon head-to-head with Metformin by a highly respected hospital. If the results are anywhere close to what is indicated by the following information, Sucanon will be a blockbuster drug.

================================================================================================================

A quick comparison of Sucanon vs Metformin as to which reduces blood sugar more. This is pretty unscientific but it looks like results should be very similar based on a "head-to-head" competition.

Metformin:
http://www.diabetesnet.com/about-diabetes/diabetes-medications/metformin

The 3rd paragraph says:
Metformin lowers fasting blood glucose levels by an average of 25% (17 to 37%), postprandial blood glucose up to 44.5%, and the A1c by an average of 1.5% (0.8 to 3.1%).

Sucanon:
http://www.pharmaroth.com/clinical_summary.asp

Clinical studies have shown that Sucanon® reduces blood sugar readings by about 25% - 30% and brings high blood sugar back into the normal range (non-fasting blood sugar is above 200 mg/dL (milligrams per deciliter) or fasting blood sugar is above 126 mg/dL).

More test info: http://www.pharmaroth.com/clinical_results.asp


Looks like it should be a really close competition, but even if Sucanon comes in a little worse than Metformin, Sucanon has no negative side effects.